
On May 1, 2026, the RCEP Secretariat announced the formal launch of a new import fast track for infant feeding products across ASEAN member states — covering bottles, breast pumps, and baby food processors. This development directly impacts manufacturers, exporters, and supply chain operators in China’s infant care equipment sector, particularly those holding NMPA Class II medical device registration certificates. It signals a meaningful reduction in regulatory duplication and time-to-market for compliant Chinese-made products entering key ASEAN markets.
Effective May 1, 2026, the ASEAN nations activated a dedicated import fast track for infant feeding and care products under the Regional Comprehensive Economic Partnership (RCEP) framework. According to the RCEP Secretariat’s official notification, Chinese manufacturers holding valid NMPA Class II medical device registration certificates — already filed with relevant Chinese authorities — may now bypass redundant type testing requirements imposed by national standards bodies such as Thailand’s TISI and Vietnam’s TCVN. As a result, customs clearance time is reduced by 5–7 working days. The fast track applies to the full Infant Feeding & Care product category. Pilot shipments from several manufacturers based in Shenzhen and Ningbo have already cleared customs under this mechanism.
Direct Exporters and Trade Enterprises: These firms handle cross-border shipment and regulatory compliance documentation. They are affected because the fast track replaces country-specific conformity assessments with a single upstream certification (NMPA Class II). Impact includes faster turnaround per shipment, lower third-party testing costs, and reduced reliance on local representatives for pre-market approval support.
Manufacturing Enterprises (OEM/ODM): Factories producing infant feeding devices — especially those already certified under China’s NMPA Class II regime — face revised internal compliance workflows. Impact centers on documentation readiness: NMPA certificate validity, labeling alignment with ASEAN language and safety markings, and traceability records required for fast-track verification.
Supply Chain and Logistics Service Providers: Freight forwarders, customs brokers, and warehousing partners handling ASEAN-bound infant care goods must update their operational checklists. Impact includes new document validation steps (e.g., confirming NMPA certificate scope covers the exact model and intended use), tighter coordination windows due to accelerated clearance timelines, and potential demand shifts toward faster inland transport options.
While the RCEP Secretariat issued the announcement, actual enforcement depends on national adoption — e.g., whether Malaysia’s SIRIM or Indonesia’s Kemenperin has published procedural notices. Companies should track updates via ASEAN national standards agencies and customs portals, not rely solely on the RCEP-level statement.
The fast track only applies if the NMPA registration explicitly covers the specific device model, its intended use (e.g., ‘for infants aged 0–24 months’), and technical specifications aligned with ASEAN safety expectations. Firms should audit existing certificates against planned export SKUs — especially for multi-function units like smart breast pumps with integrated sterilization.
This is a framework-level facilitation, not an automatic approval mechanism. Customs officers at port-of-entry retain discretion to request supplementary evidence. Companies should treat the fast track as a conditional acceleration tool — not a waiver — and maintain full test reports and risk management files for audit purposes.
Required documents include: (i) valid NMPA Class II certificate with English translation certified by a notary or embassy; (ii) declaration of conformity referencing ASEAN harmonized standards (where applicable); (iii) product labeling samples showing bilingual (English + local language) warnings and usage instructions. Early preparation avoids delays during peak shipping windows.
Observably, this fast track represents an early-stage institutionalization of regulatory mutual recognition within RCEP — but limited to a narrowly defined product category and contingent on pre-existing Chinese regulatory infrastructure (NMPA Class II). Analysis shows it functions less as a standalone trade liberalization measure and more as a targeted efficiency layer atop existing national frameworks. From an industry perspective, its significance lies not in immediate scale — current coverage remains confined to three product types — but in its precedent value: it demonstrates feasibility of aligning medical-device-adjacent consumer product rules across diverse ASEAN regulatory systems. Continued monitoring is warranted, as expansion to other categories (e.g., baby monitors, wearable thermometers) would depend on ASEAN members’ willingness to accept upstream certifications beyond NMPA.

Conclusion: This initiative marks a procedural milestone rather than a structural shift. It lowers friction for a subset of compliant Chinese exporters but does not eliminate national regulatory sovereignty or alter fundamental market access conditions. Currently, it is best understood as a pilot-aligned facilitation — valuable where applicable, but requiring careful, case-by-case validation before operational deployment.
Source: RCEP Secretariat official notification (issued May 1, 2026). Note: Implementation details at the national level (e.g., customs procedures, acceptable certificate formats, language requirements) remain subject to ongoing clarification by individual ASEAN member states and are not yet fully consolidated in public guidance.
Related Intelligence